Community care assessment of exacerbations of chronic obstructive pulmonary disease

Journal of Advanced Nursing

Volumn 66, Issue 11, 2010, Pages 2490-2499

  Hutchinson, Anastasia F ^a   Thompson, Michelle A ^b   Brand, Caroline A ^a   Black, Jim ^a   Anderson, Gary P ^a   Irving, Louis B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Community; Dyspnoea; Exacerbation severity; Respiratory nurse practitioners

Indexed keywords

ABNORMAL RESPIRATORY SOUND; ALGORITHM; AMBULATORY CARE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY CARE; DECISION SUPPORT SYSTEM; DISEASE COURSE; DYSPNEA; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; METHODOLOGY; NURSE PRACTITIONER; NURSING; NURSING ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; QUALITY OF LIFE;

ALGORITHMS; AMBULATORY CARE; COMMUNITY HEALTH SERVICES; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DYSPNEA; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; NURSE PRACTITIONERS; NURSING ASSESSMENT; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX;

EID: 78649452549     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2010.05436.x     Document Type: Article

References (41)

1. Ambrosino N. & Scano G. (2004) Dyspnoea and its measurement. Breathe 1(2), 101-107.
2. American Thoracic Society (ATS) (2004) COPD Guidelines 2004. Retrieved from on February 2004.
3. Anthonisen N.R., Manfreda J., Warren C.P.W., Hershfield E.S., Harding G.K.M. & Nelson N.A. (1987) Antibiotic therapy in exacerbations of Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine 106(2), 196-204.
4. Benfield T., Lange P. & Vestbo J. (2008) Chronic obstructive pulmonary disease stage and risk of hospitalization for infectious disease. Chest 134(1), 46-53.
5. Bestall J., Paul E., Garrod R., Garnham R., Jones P. & Wedzicha J. (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54(7), 581-586.
6. Bozinovski S., Hutchinson A.F., Thompson M.A., MacGregor L., Black J., Giannakis E., Karlsson A.-S., Silvestrini R., Smallwood D., Vlahos R., Irving L.B. & Anderson G.P.A. (2008) Serum Amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 177(3), 269-278.
7. British Thoracic Society (BTS) Guideline Development Group (2007) Intermediate care - hospital in the home in chronic obstructive pulmonary disease. Thorax 63(3), 200-210.
8. Burge S. & Wedzicha J.A. (2003) COPD exacerbations: definitions and classifications. European Respiratory Journal - Supplement 41, 46s-53s.
9. Calverley P. (2005) Minimal clinically important difference-exacerbations of COPD. COPD: Journal of Obstructive Pulmonary Disease 2(1), 143-148.
10. Calverley P., Pauwels R., Lofdahl C.-G., Svensson K., Higenbottam T., Carlsson L.-G. & Stahl E. (2005) Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. European Respiratory Journal 26(3), 406-413.
11. Cotton M., Bucknall C., Dagg K., Johnson M., MacGregor G., Stewart C. & Stevenson R. (2000) Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 55(11), 902-906.
12. Davies L., Wilkinson M., Bonner S., Calverley P.M.A. & Angus R.M. (2000) ''Hospital at home'' versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. British Medical Journal 321(7271), 1265-1268.
13. Dewan N.A., Rafique S., Kanwar B., Satpathy H., Ryschon K., Tillotson G.S. & Niederman M.S. (2000) Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 117(3), 662-671.
14. Franciosi L., Page C.P., Celli B.R., Cazzola M., Walker M.J., Danhof M., Rabe K.F. & Della Pasqua O.E. (2006) Markers of exacerbation severity in chronic obstructive pulmonary disease. Respiratory Research 7(1), 74-91.
15. GraphPad Software (2008) Graphpad Prism Version 5. Retrieved from on June 2006.
16. Hanley J. & McNeil B.J. (1983) A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 148(3), 839-843.
17. Hutchinson A., Ghimire A.K., Thompson M.A., Black J.F., Brand C.A., Lowe A.J., Smallwood D.M., Valhos R., Bozinovski S., Brown G.V., Anderson G.P.A. & Irving L.B. (2007) A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respiratory Medicine 101(12), 2472-2481.
18. Jones P., Quirk F., Baveystock C. & Littlejohns P. (1992) A self-complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire. American Review of Respiratory Disease 145(6), 1321-1327.
19. Kendrick K., Baxi S.C. & Smith R.M. (2000) Usefulness of the modified 0-10 Borg Scale in assessing the degree of dyspnea inpatients with COPD and asthma. Journal of Emergency Nursing 26(3), 216-222.
20. Kessler R., Faller M., Fourgaut G., Mennecier B. & Weitzenblum E. (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 159(1), 158-164.
21. Kirkwood B. & Sterne J. (2005) Essential Medical Statistics, 2nd edn. Blackwell Sciences LTD, Oxford.
22. Miravitlles M., Guerrero T., Mayordomo C., Sánchez-Agudo L., Nicolau F., Segú J.E. & on behalf of the EOLO Study Group (2000) Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67(5), 495-501.
23. Miravitlles M., Murio C. & Guerrero T. (2001) Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. European Respiratory Journal 17(5), 928-933.
24. Murray J. (1997) Alternative projections of mortality and disability by cause 1990-2020. Global burden of disease study. The Lancet 349(9064), 1498-1504.
25. National Institutes of Health - NHLBI (2001). Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (68). Retrieved from on July 2002.
26. NICE - National Institute of Clinical Excellence (2004) Management of chronic obstructive pulmonary disease in adults in primary and secondary care. Retrieved from on June 2005.
27. Pepe M.S. (2003) The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford University Press, Oxford.
28. Pinto-Plata V., Toso J., Lee K., Parks D., Bilello J., Mullerova H., Desouza M., Vessey R.S. & Celli B. (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62, 595-601.
29. Ram F.S.F., Wedzicha J.A., Wright J. & Greenstone M. (2004) Hospital at home for acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. British Medical Journal 329(7461), 315-318.
30. Sackett D., Haynes R.B., Guyatt G.H. & Tugwell P. (1991) The Interpretation of Diagnostic Data. Clinical Epidemiology. A Basic Science for Clinical Medicine, 2nd edn. Little/Brown and Co., Boston, pp. 69-152.
31. Schunemann H., Griffith L., Jaeschke R., Goldstein R., Stubbing D. & Guyatt G.H. (2003) Evaluation of the minimal important difference for the feeling thermometer and the St George Respiratory Questionnaire in patients with chronic airflow limitation. Journal of Clinical Epidemiology 56(12), 1170-1176.
32. Seemungal T., Donaldson G., Paul E., Bestall J., Jeffries D. & Wedzicha J. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 157(5), 1418-1422.
33. Seemungal T., Donaldson G., Bhowmik A., Jeffries D. & Wedzicha J. (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 161(5), 1608-1613.
34. Selim A., Ren X., Fincke G., Rogers W., Lee A. & Kazis L. (1997) A Symptom-based measure of the severity of chronic lung disease*. Results from the Veterans Health Study. Chest 111(6), 1607-1614.
35. Skwarska E., Cohen G., Skwarski K.M., Lamb C., Bushell D., Parker S. & MacNee W. (2000) Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 55(11), 907-912.
36. StataCorp LP (2005) STATA Data analysis and Statistical Software. Retrieved from on December 2005.
37. Strassels S. (2001) The costs of treating COPD in the United States. Chest 119(2), 344-352.
38. Volpe K.D. (2001) Early discharge is safe for some COPD patients. Pulmonary Reviews 6(2), 1-5. Retrieved from on May 2008.
39. Wedzicha J. (2001) Airway Infection accelerates decline of lung function in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Medicine 164(10), 1757-1760.
40. Wedzicha J. (2002) Exacerbations: etiology and pathophysiologic mechanisms. Chest 121 (5 Suppl.), 136S-141S.
41. Yende S., Tuormanen E.I., Wunderlink R., Kanaya A., Newman A.B., Harris T., De Rekeneire N., Kritchevsky S.B. & for the Health ABC Study (2005) Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. American Journal of Respiratory & Critical Care Medicine 172(11), 1440-1446.